Scholarly Index
Michael O. Thorner
Lumos Pharma (United States); 30,139 total citations; 369 total publications; best world rank #37
Lumos Pharma (United States)
30,139Total citations
369Total publications
88H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 39 | US 21 | 99.59 |
| Pituitary Gland Disorders and Treatments | Lifetime | 37 | US 12 | 99.67 |
| Diet and metabolism studies | Lifetime | 488 | US 215 | 99.09 |
| Regulation of Appetite and Obesity | Lifetime | 334 | US 158 | 97.91 |
| Adrenal Hormones and Disorders | Lifetime | 242 | US 95 | 97.33 |
| Neuroendocrine Tumor Research Advances | Lifetime | 845 | US 324 | 97.44 |
| Thyroid Disorders and Treatments | Lifetime | 430 | US 162 | 97.09 |
| Adrenal and Paraganglionic Tumors | Lifetime | 452 | US 159 | 96.23 |
| Hypothalamic control of reproductive hormones | Lifetime | 356 | US 193 | 96.25 |
| Lipid metabolism and disorders | Lifetime | 823 | US 281 | 92.48 |
| Genetic Syndromes and Imprinting | Lifetime | 940 | US 351 | 91.98 |
| Growth Hormone and Insulin-like Growth Factors | 2021-2025 | 445 | US 88 | 82.46 |